Abstract:Abstract Background: This study aims to perform bioinformatics analysis of programmed cell death-related genes (PCDGs) in osteosarcoma, and to construct a multi-gene signature for predicting the prognosis.Methods: The functional enrichment analysis was applied for prognostic PCDGs, and PPI network as well as drug-gene interactions were constructed. In order to set up the prognosis evaluation system, we established a prognosis model by integrating PCDGs. The Least Absolute Shrinkage and Selection Operator (LASSO) logistic regression analysis as well as the multivariate Cox proportional hazard regression analysis were used to construct the five-genes signature (MUC1, TCF7L2, TGFB2, TRIAP1, CBS) for prediction in Gene Expression Omnibus (GEO) cohort. According to the median risk score, survival analysis was conducted to evaluate the prognostic value of the risk score in GEO cohort. Next, by combining other clinic-pathological independent prognostic factor, stage at diagnosis, a nomogram was established to predict individual survival probability. Result: GO analysis showed that the 15 prognostic PCDGs were mainly enriched in apoptotic signaling pathway, regulation of secretion and p53 signaling pathway. KEGG analysis showed that aforesaid genes were mainly related to PI3K-Akt signaling pathway, diverse neoplasms signaling pathway and hepatitis B. Drug-gene interactions displayed available drugs for influencing osteosarcoma via programmed cell death, such as adalimumab, tacrolimus and sirolimus. The risk score was constructed based on 5 genes and patients were significantly divided into high-risk and low-risk groups according to overall survival. In multivariate Cox regression analysis, risk score was still an independent prognostic factor (HR = 2.526, 95% CI = 1.597−3.994, P < 0.001). Cumulative curve showed that low-risk score patients were significantly had better prognosis than that of patients with high-risk score (P < 0.001). The external independent TARGET cohort proved the validity of risk score model and the nomograph.Conclusion: From the facet of programmed cell death, we provided a multi-gene signatureand the nomograph for the prognostic predictors of osteosarcoma patients, and available drugs displayed may provide promising treatment strategies.

Reference Gene Expression in Human Osteosarcoma Cell Lines Treated by Egb and Ctx

Identification of Optimal Reference Genes for Gene Expression Normalization in Human Osteosarcoma Cell Lines under Proliferative Conditions

Identification of a Programmed Cell Death-related Signature for Prediction of Osteosarcoma

Identification of suitable reference genes for gene expression studies of human serous ovarian cancer by real-time polymerase chain reaction.

Selection of Suitable Reference Genes for Normalization of Quantitative Real-Time Polymerase Chain Reaction in Human Cartilage Endplate of the Lumbar Spine

TBP, PPIA, YWHAZ and EF1A1 Are the Most Stably Expressed Genes during Osteogenic Differentiation

Comparison of Reference Gene Expression Stability in Mouse Skeletal Muscle Via Five Algorithms.

Identification of Tumorigenicity-Associated Genes in Osteosarcoma Cell Lines Based on Bioinformatic Analysis and Experimental Validation.

Evaluation of the Stability of Reference Genes in Bone Mesenchymal Stem Cells from Patients with Avascular Necrosis of the Femoral Head.

Identification of Suitable Reference Genes for Measurement of Gene Expression in Human Cervical Tissues.

Tissue-specific Selection of Optimal Reference Genes for Expression Analysis of Anti-Cancer Drug-Related Genes in Tumor Samples Using Quantitative Real-Time RT-PCR.

Identification of suitable reference genes for gene expression studies using quantitative polymerase chain reaction in lung cancer in vitro.

Comparative Analysis of Reference Gene Stability in Human Mesenchymal Stromal Cells During Osteogenic Differentiation

Reference Gene Selection for RT-qPCR Gene Expression in Researches of Craniosynostosis

Evaluation and Validation of Suitable Reference Genes for Reverse Transcription-Quantitative Polymerase Chain Reaction Studies in Cholangiocarcinoma Patients and Cell Lines.

Selection of Internal References for Qrt-Pcr Assays of Human Hepatocellular Carcinoma Cell Lines

Identification of Reference Genes for Qrt-Pcr in Human Lung Squamous-Cell Carcinoma by RNA-Seq.

Bone to Pick: the Importance of Evaluating Reference Genes for RT-qPCR Quantification of Gene Expression in Craniosynostosis and Bone-Related Tissues and Cells

Identification of CD20, ECM, and ITGA as Biomarkers for Osteosarcoma by Integrating Transcriptome Analysis

Identification and Validation of Common Reference Genes for Normalization of Esophageal Squamous Cell Carcinoma Gene Expression Profiles

Identification of optimal reference genes for quantitative PCR studies on human mesenchymal stem cells.